MAXIPHARMA A/S: Financial statements 2024
CVR: 87375617
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MAXIPHARMA A/S (CVR 87375617) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,144,691 and a net result of DKK 411,322 compared with DKK 226,485 the year before. That is an increase of 17.5% compared with the year before. Equity in the 2024 report amounted to DKK 3,973,700. The solvency ratio was 81.4%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,144,691
- Profit/Loss
- DKK 411,322
- Equity
- DKK 3,973,700
- Total Assets
- DKK 4,881,383
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2.1 mio. | 411 t. | 4 mio. | 3 |
| 2023 | - | 1.8 mio. | 226 t. | 3.8 mio. | 2 |
| 2022 | - | 2 mio. | 265 t. | 3.7 mio. | 2 |
| 2021 | - | 1.7 mio. | 988 t. | 3.7 mio. | 2 |
| 2020 | - | 1.5 mio. | 746 t. | 3.4 mio. | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
MAXIPHARMA A/S has published its annual report for 2023. Gross profit came to DKK 1,824,624, and the net result was DKK 226,485.
About MAXIPHARMA A/S
MAXIPHARMA A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1979. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jesper Bjerre Jensen. The board consists of Benedikte Mailand Jensen (chair), Henrik Bencke and Jesper Bjerre Jensen. The company is owned by AKTIESELSKABET SGJ. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 1,791,625 and a net result of DKK 434,996 compared with DKK 411,322 the year before. Equity in the 2025 report amounted to DKK 4,204,696.